应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02160 心通医疗-B
耶稣受难节休市 03-28 16:08:03
1.130
+0.070
+6.60%
最高
1.160
最低
1.020
成交量
1,547万
今开
1.070
昨收
1.060
日振幅
13.21%
总市值
27.26亿
流通市值
27.26亿
总股本
24.13亿
成交额
1,696万
换手率
0.64%
流通股本
24.13亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
心通医疗-B03月28日遭主力抛售122万元 环比增加293.55%
自选股智能写手 · 03-28 16:15
心通医疗-B03月28日遭主力抛售122万元 环比增加293.55%
心通医疗-B(02160)出现大手卖出150万股,成交价$1.13,涉资169.5万
阿斯达克财经 · 03-28 16:08
心通医疗-B(02160)出现大手卖出150万股,成交价$1.13,涉资169.5万
心通医疗-B(02160)上涨6.6%,报1.13元/股
金融界 · 03-28 15:35
心通医疗-B(02160)上涨6.6%,报1.13元/股
心通医疗-B盘中异动 临近收盘股价大涨5.75%报1.121港元
自选股智能写手 · 03-28 15:35
心通医疗-B盘中异动 临近收盘股价大涨5.75%报1.121港元
心通医疗-B(02160)股价上升5.66%,现价港币$1.12
阿斯达克财经 · 03-28 15:35
心通医疗-B(02160)股价上升5.66%,现价港币$1.12
《公司业绩》心通医疗-B(02160.HK)去年亏损扩大至4.72亿元人民币
阿斯达克财经 · 03-28 11:26
《公司业绩》心通医疗-B(02160.HK)去年亏损扩大至4.72亿元人民币
心通医疗-B(02160.HK) 2023年度财报揭晓:收入增长33.9%,毛利增长41.8%
和讯网 · 03-28 05:58
心通医疗-B(02160.HK) 2023年度财报揭晓:收入增长33.9%,毛利增长41.8%
心通医疗-B(02160)发布2023年度业绩,股东应占亏损4.72亿元,亏损扩大3.8%
智通财经 · 03-27 23:09
心通医疗-B(02160)发布2023年度业绩,股东应占亏损4.72亿元,亏损扩大3.8%
心通医疗-B(02160)上涨5.71%,报1.11元/股
金融界 · 03-27 13:23
心通医疗-B(02160)上涨5.71%,报1.11元/股
心通医疗-B盘中异动 下午盘急速拉升5.81%
自选股智能写手 · 03-27 13:23
心通医疗-B盘中异动 下午盘急速拉升5.81%
心通医疗-B(02160)股价上升5.714%,现价港币$1.11
阿斯达克财经 · 03-27 13:23
心通医疗-B(02160)股价上升5.714%,现价港币$1.11
心通医疗-B盘中异动 下午盘大幅下挫5.22%报1.071港元
自选股智能写手 · 03-25
心通医疗-B盘中异动 下午盘大幅下挫5.22%报1.071港元
心通医疗-B(02160)下跌5.31%,报1.07元/股
金融界 · 03-25
心通医疗-B(02160)下跌5.31%,报1.07元/股
心通医疗-B(02160)下跌5.74%,报1.15元/股
金融界 · 03-19
心通医疗-B(02160)下跌5.74%,报1.15元/股
心通医疗-B盘中异动 下午盘股价大跌5.74%
自选股智能写手 · 03-19
心通医疗-B盘中异动 下午盘股价大跌5.74%
心通医疗-B(02160)股价下跌5.738%,现价港币$1.15
阿斯达克财经 · 03-19
心通医疗-B(02160)股价下跌5.738%,现价港币$1.15
心通医疗-B(02160.HK)将于3月27日举行董事会会议以审批全年业绩
格隆汇资讯 · 03-15
心通医疗-B(02160.HK)将于3月27日举行董事会会议以审批全年业绩
心通医疗-B03月11日遭主力抛售72万元 环比增加200.00%
自选股智能写手 · 03-11
心通医疗-B03月11日遭主力抛售72万元 环比增加200.00%
心通医疗-B(02160)下跌5.97%,报1.26元/股
金融界 · 03-05
心通医疗-B(02160)下跌5.97%,报1.26元/股
心通医疗-B盘中异动 早盘股价大跌6.04%报1.260港元
自选股智能写手 · 03-05
心通医疗-B盘中异动 早盘股价大跌6.04%报1.260港元
公司概况
公司名称:
心通医疗-B
所属市场:
SEHK
上市日期:
--
主营业务:
微创心通医疗科技有限公司是一家主要从事医疗器械行业的中国投资控股公司。该公司主要从事心脏瓣膜疾病领域经导管及手术解决方案的研发和商业化。该公司主要产品包括第一代经导管主动脉瓣植入(TAVI)产 品“VitaFlow”和第二代TAVI产品“VitaFlow II”。该公司主要于国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02160","market":"HK","secType":"STK","nameCN":"心通医疗-B","latestPrice":1.13,"timestamp":1711613283016,"preClose":1.06,"halted":0,"volume":15472000,"delay":0,"floatShares":2412592839,"shares":2412592839,"eps":-0.21564588,"marketStatus":"耶稣受难节休市","marketStatusCode":7,"change":0.07,"latestTime":"03-28 16:08:03","open":1.07,"high":1.16,"low":1.02,"amount":16955910,"amplitude":0.132075,"askPrice":1.13,"askSize":146000,"bidPrice":1.12,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":-0.21564588583324207,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1712021400000},"adr":0,"listingDate":1612368000000,"adjPreClose":1.06,"openAndCloseTimeList":[[1711589400000,1711598400000],[1711602000000,1711612800000]],"volumeRatio":2.8039228969351804,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02160/wiki","defaultTab":"wiki","newsList":[{"id":"2422155589","title":"心通医疗-B03月28日遭主力抛售122万元 环比增加293.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422155589","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422155589?lang=zh_cn&edition=full","pubTime":"2024-03-28 16:15","pubTimestamp":1711613750,"startTime":"0","endTime":"0","summary":"03月28日, 心通医疗-B股价涨6.60%,报收1.13元,成交金额1695万元,换手率0.64%,振幅13.21%,量比2.80。心通医疗-B今日主力资金净流出122万元,上一交易日主力净流出31万元,今日环比增加293.55%。该股近5个交易日下跌7.76%,主力资金累计净流出135万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出435万元,其中净流出天数为10日。该股主力净额占比0.05%,港股市场排名2558/2625。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032816161787bfb9a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032816161787bfb9a1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422155395","title":"心通医疗-B(02160)出现大手卖出150万股,成交价$1.13,涉资169.5万","url":"https://stock-news.laohu8.com/highlight/detail?id=2422155395","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422155395?lang=zh_cn&edition=full","pubTime":"2024-03-28 16:08","pubTimestamp":1711613280,"startTime":"0","endTime":"0","summary":"[大手成交]心通医疗-B(02160)在下午04:08出现大手卖出,成交量为150万,成交价为港币$1.13,涉资169.5万。至目前为止,股价升6.604%,今日最高价为$1.16,而最低价为$1.02,总成交量为1.546千万股,总成交金额港币$1.694千万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2403283552/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2422615857","title":"心通医疗-B(02160)上涨6.6%,报1.13元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2422615857","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422615857?lang=zh_cn&edition=full","pubTime":"2024-03-28 15:35","pubTimestamp":1711611337,"startTime":"0","endTime":"0","summary":"3月28日,心通医疗-B盘中上涨6.6%,截至15:35,报1.13元/股,成交566.41万元。公司自主研发的第一代和第二代经导管主动脉瓣植入产品VitaFlow和VitaFlow Liberty已分别于2019年和2021年获得国家药监局审批上市,并已在中国进行商业化,同时第二代产品VitaFlow Liberty正在欧洲进行临床试验。截至2023年年报,心通医疗-B营业总收入3.36亿元、净利润-4.72亿元。3月27日,2023财年年报归属股东应占溢利-4.715亿人民币,同比下降3.77%,基本每股收益-0.2人民币。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/28153540035153.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422134258","title":"心通医疗-B盘中异动 临近收盘股价大涨5.75%报1.121港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422134258","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422134258?lang=zh_cn&edition=full","pubTime":"2024-03-28 15:35","pubTimestamp":1711611333,"startTime":"0","endTime":"0","summary":"2024年03月28日临近收盘15时35分,心通医疗-B股票出现异动,股价快速拉升5.75%。截至发稿,该股报1.121港元/股,成交量523.4万股,换手率0.22%,振幅10.38%。其相关个股中,华检医疗、心通医疗-B、佳兆业健康涨幅较大,振幅较大的相关个股有健世科技-B、佳兆业健康、先瑞达医疗-B,振幅分别为26.59%、17.39%、14.64%。同时,于2023年,随着集团的TAVI产品于海外市场的拓展,集团自海外销售TAVI产品产生的收入较上年增长58.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328153533861e2143&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240328153533861e2143&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422137309","title":"心通医疗-B(02160)股价上升5.66%,现价港币$1.12","url":"https://stock-news.laohu8.com/highlight/detail?id=2422137309","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422137309?lang=zh_cn&edition=full","pubTime":"2024-03-28 15:35","pubTimestamp":1711611300,"startTime":"0","endTime":"0","summary":"[上升股]心通医疗-B(02160) 股价在下午03:35比前收市价上升5.66%,现股价为港币$1.12。至目前为止,今日最高价为$1.12,而最低价为$1.02。总成交量为508万股,总成交金额为港币$539.212万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152552334_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2403284802/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2422183318","title":"《公司业绩》心通医疗-B(02160.HK)去年亏损扩大至4.72亿元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2422183318","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422183318?lang=zh_cn&edition=full","pubTime":"2024-03-28 11:26","pubTimestamp":1711596360,"startTime":"0","endTime":"0","summary":"心通医疗-B(02160.HK) 公布截至去年12月底止全年业绩,营业额3.36亿元人民币(下同),按年升33.9%。亏损扩大至4.72亿元,上年同期蚀4.54亿元;每股亏损0.2元。不派息。(cy/w)(港股报价延迟最少十五分钟。沽空资料截至 2024-03-27 16:25。)过往派息公布日期派息事项派息内容2023/08/29中期业绩无派息2023/03/29末期业绩无派息 2022/08/29中期业绩无派息 2022/03/29末期业绩无派息 AASTOCKS新闻","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220906143936150_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220906143936150_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1338215/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2422782639","title":"心通医疗-B(02160.HK) 2023年度财报揭晓:收入增长33.9%,毛利增长41.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422782639","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2422782639?lang=zh_cn&edition=full","pubTime":"2024-03-28 05:58","pubTimestamp":1711576710,"startTime":"0","endTime":"0","summary":"毛利约为人民币2.3亿元,同比增加了41.8%。然而,公司权益股东应占亏损约为人民币4.72亿元,略高于去年同期的人民币4.54亿元。每股基本亏损为人民币0.20元。尽管营收和毛利出现显著增长,但公司仍面临亏损的挑战。快讯正文心通医疗-B最新发布了2023年度财报。根据公告,该公司在截至2023年12月31日的一年中取得了不错的业绩。和讯竭力但不能证实上述内容的真实性、准确性和原创性,对此和讯不做任何保证和承诺。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032806433087bdd405&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032806433087bdd405&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422911651","title":"心通医疗-B(02160)发布2023年度业绩,股东应占亏损4.72亿元,亏损扩大3.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422911651","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2422911651?lang=zh_cn&edition=full","pubTime":"2024-03-27 23:09","pubTimestamp":1711552153,"startTime":"0","endTime":"0","summary":"智通财经APP讯,心通医疗-B(02160)公布截至2023年12月31日止年度业绩,该集团录得收入3.36亿元人民币,同比增长33.9%,公司权益股东应占亏损4.72亿元人民币,亏损扩大3.8%,每股亏损0.2元。报告显示,收入增加33.9%,主要是由集团TAVI产品在中国的入院数增加带来手术量的快速增长,令集团的TAVI产品在中国的销售额增加。同时,于2023年,随着集团的TAVI产品于海外市场的拓展,集团自海外销售TAVI产品产生的收入较上年增长58.9%。截至2023年12月31日,集团的TAVI产品已进入阿根廷、哥伦比亚、泰国及俄罗斯的近百家海外医院。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1094084.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422793366","title":"心通医疗-B(02160)上涨5.71%,报1.11元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2422793366","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422793366?lang=zh_cn&edition=full","pubTime":"2024-03-27 13:23","pubTimestamp":1711517004,"startTime":"0","endTime":"0","summary":"3月27日,心通医疗-B(02160)盘中上涨5.71%,截至13:23,报1.11元/股,成交252.85万元。微创心通医疗科技有限公司是一家专注于心脏瓣膜疾病领域的创新的经导管及手术解决方案的研发和商业化的医疗器械企业。公司自主研发的第一代和第二代经导管主动脉瓣植入产品VitaFlow和VitaFlow Liberty已分别于2019年和2021年获得国家药监局审批上市,并已在中国进行商业化,同时第二代产品VitaFlow Liberty正在欧洲进行临床试验。截至2023年中报,心通医疗-B营业总收入1.76亿元、净利润-1.79亿元。3月27日,心通医疗-B披露2023财年年报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/27132340012162.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422332309","title":"心通医疗-B盘中异动 下午盘急速拉升5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422332309","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422332309?lang=zh_cn&edition=full","pubTime":"2024-03-27 13:23","pubTimestamp":1711516998,"startTime":"0","endTime":"0","summary":"2024年03月27日下午盘13时23分,心通医疗-B股票出现波动,股价急速上涨5.81%。截至发稿,该股报1.111港元/股,成交量233.7万股,换手率0.10%,振幅5.71%。心通医疗-B股票所在的医疗设备及用品行业中,整体跌幅为0.02%。其相关个股中,威高股份、鹰瞳科技-B、心通医疗-B涨幅较大,振幅较大的相关个股有健世科技-B、巨星医疗控股、紫元元,振幅分别为11.24%、10.17%、10.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271323187a4f6049&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403271323187a4f6049&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422933932","title":"心通医疗-B(02160)股价上升5.714%,现价港币$1.11","url":"https://stock-news.laohu8.com/highlight/detail?id=2422933932","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2422933932?lang=zh_cn&edition=full","pubTime":"2024-03-27 13:23","pubTimestamp":1711516980,"startTime":"0","endTime":"0","summary":"[上升股]心通医疗-B(02160) 股价在下午01:23比前收市价上升5.714%,现股价为港币$1.11。至目前为止,今日最高价为$1.11,而最低价为$1.05。总成交量为233.7万股,总成交金额为港币$252.849万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133337750_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2403271690/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2422155704","title":"心通医疗-B盘中异动 下午盘大幅下挫5.22%报1.071港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2422155704","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422155704?lang=zh_cn&edition=full","pubTime":"2024-03-25 14:10","pubTimestamp":1711347039,"startTime":"0","endTime":"0","summary":"2024年03月25日下午盘14时10分,心通医疗-B股票出现异动,股价大幅下跌5.22%。截至发稿,该股报1.071港元/股,成交量372.001万股,换手率0.15%,振幅7.08%。资金方面,该股资金流入123.398万港元,流出224.953万港元。心通医疗-B股票所在的医疗设备及用品行业中,整体跌幅为0.07%。其相关个股中,润迈德-B、智云健康、高视医疗涨幅较大,振幅较大的相关个股有智云健康、高视医疗、沛嘉医疗-B,振幅分别为16.78%、13.49%、9.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032514103987e7b5bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032514103987e7b5bb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422784552","title":"心通医疗-B(02160)下跌5.31%,报1.07元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2422784552","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422784552?lang=zh_cn&edition=full","pubTime":"2024-03-25 14:10","pubTimestamp":1711347038,"startTime":"0","endTime":"0","summary":"3月25日,心通医疗-B(02160)盘中下跌5.31%,截至14:10,报1.07元/股,成交409.7万元。微创心通医疗科技有限公司是一家专注于心脏瓣膜疾病领域的创新的经导管及手术解决方案的研发和商业化的医疗器械企业。公司自主研发的第一代和第二代经导管主动脉瓣植入产品VitaFlow和VitaFlow Liberty已分别于2019年和2021年获得国家药监局审批上市,并已在中国进行商业化,同时第二代产品VitaFlow Liberty正在欧洲进行临床试验。截至2023年中报,心通医疗-B营业总收入1.76亿元、净利润-1.79亿元。3月27日,心通医疗-B将披露2023财年年报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/25141039976045.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2420529049","title":"心通医疗-B(02160)下跌5.74%,报1.15元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2420529049","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2420529049?lang=zh_cn&edition=full","pubTime":"2024-03-19 15:14","pubTimestamp":1710832476,"startTime":"0","endTime":"0","summary":"3月19日,心通医疗-B(02160)盘中下跌5.74%,截至15:14,报1.15元/股,成交515.49万元。微创心通医疗科技有限公司是一家专注于心脏瓣膜疾病领域的创新的经导管及手术解决方案的研发和商业化的医疗器械企业。公司自主研发的第一代和第二代经导管主动脉瓣植入产品VitaFlow和VitaFlow Liberty已分别于2019年和2021年获得国家药监局审批上市,并已在中国进行商业化,同时第二代产品VitaFlow Liberty正在欧洲进行临床试验。截至2023年中报,心通医疗-B营业总收入1.76亿元、净利润-1.79亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/19151439901962.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2420290430","title":"心通医疗-B盘中异动 下午盘股价大跌5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420290430","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420290430?lang=zh_cn&edition=full","pubTime":"2024-03-19 15:14","pubTimestamp":1710832475,"startTime":"0","endTime":"0","summary":"2024年03月19日下午盘15时14分,心通医疗-B股票出现波动,股价急速下跌5.74%。截至发稿,该股报1.150港元/股,成交量435.505万股,换手率0.18%,振幅5.74%。心通医疗-B股票所在的医疗设备及用品行业中,整体跌幅为0.16%。其相关个股中,佳兆业健康、华检医疗、永胜医疗涨幅较大,振幅较大的相关个股有佳兆业健康、紫元元、巨星医疗控股,振幅分别为61.90%、22.61%、14.71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031915143587e7a020&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031915143587e7a020&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420921826","title":"心通医疗-B(02160)股价下跌5.738%,现价港币$1.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2420921826","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2420921826?lang=zh_cn&edition=full","pubTime":"2024-03-19 15:14","pubTimestamp":1710832440,"startTime":"0","endTime":"0","summary":"[下跌股]心通医疗-B(02160) 股价在下午03:14比前收市价下跌5.738%,现股价为港币$1.15。至目前为止,今日最高价为$1.22,而最低价为$1.15。总成交量为340.404万股,总成交金额为港币$404.633万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152743541_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2403191694/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2419942058","title":"心通医疗-B(02160.HK)将于3月27日举行董事会会议以审批全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2419942058","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2419942058?lang=zh_cn&edition=full","pubTime":"2024-03-15 17:04","pubTimestamp":1710493443,"startTime":"0","endTime":"0","summary":"格隆汇3月15日丨心通医疗-B(02160.HK)发布公告,公司董事会会议将于2024年3月27日举行,藉以省览及批准集团截至2023年12月31日止年度的全年业绩及其发布,并考虑派付末期股息(如有)的建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403151704158b36cdcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403151704158b36cdcb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418827433","title":"心通医疗-B03月11日遭主力抛售72万元 环比增加200.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418827433","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418827433?lang=zh_cn&edition=full","pubTime":"2024-03-11 16:15","pubTimestamp":1710144940,"startTime":"0","endTime":"0","summary":"03月11日,心通医疗-B股价收平报1.24元,成交金额858万元,换手率0.29%,振幅4.84%,量比2.43。心通医疗-B今日主力资金净流出72万元,上一交易日主力净流出24万元,今日环比增加200.00%。该股近5个交易日下跌7.46%,主力资金累计净流出179万元;近20日主力资金累计净流出85万元,其中净流出天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403111615598771176b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403111615598771176b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417482823","title":"心通医疗-B(02160)下跌5.97%,报1.26元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2417482823","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2417482823?lang=zh_cn&edition=full","pubTime":"2024-03-05 10:02","pubTimestamp":1709604132,"startTime":"0","endTime":"0","summary":"3月5日,心通医疗-B(02160)盘中下跌5.97%,截至10:02,报1.26元/股,成交122.32万元。微创心通医疗科技有限公司是一家专注于心脏瓣膜疾病领域的创新的经导管及手术解决方案的研发和商业化的医疗器械企业。公司自主研发的第一代和第二代经导管主动脉瓣植入产品VitaFlow和VitaFlow Liberty已分别于2019年和2021年获得国家药监局审批上市,并已在中国进行商业化,同时第二代产品VitaFlow Liberty正在欧洲进行临床试验。截至2023年中报,心通医疗-B营业总收入1.76亿元、净利润-1.79亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/05100239732828.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2417487587","title":"心通医疗-B盘中异动 早盘股价大跌6.04%报1.260港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417487587","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417487587?lang=zh_cn&edition=full","pubTime":"2024-03-05 10:02","pubTimestamp":1709604129,"startTime":"0","endTime":"0","summary":"2024年03月05日早盘10时02分,心通医疗-B股票出现波动,股价急速下挫6.04%。截至发稿,该股报1.260港元/股,成交量95.3万股,换手率0.04%,振幅5.97%。资金方面,该股资金流入3.668万港元,流出76.693万港元。心通医疗-B股票所在的医疗设备及用品行业中,整体跌幅为0.13%。其相关个股中,业聚医疗、HKE HOLDINGS、永胜医疗涨幅较大,振幅较大的相关个股有健世科技-B、微泰医疗-B、智云健康,振幅分别为10.53%、8.37%、8.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030510020979174d5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030510020979174d5f&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0259},{"period":"1month","weight":-0.1986},{"period":"3month","weight":-0.3025},{"period":"6month","weight":-0.3234},{"period":"1year","weight":-0.5603},{"period":"ytd","weight":-0.3025}],"compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0149},{"period":"3month","weight":-0.0297},{"period":"6month","weight":-0.0712},{"period":"1year","weight":-0.1808},{"period":"ytd","weight":-0.0297}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"微创心通医疗科技有限公司是一家主要从事医疗器械行业的中国投资控股公司。该公司主要从事心脏瓣膜疾病领域经导管及手术解决方案的研发和商业化。该公司主要产品包括第一代经导管主动脉瓣植入(TAVI)产 品“VitaFlow”和第二代TAVI产品“VitaFlow II”。该公司主要于国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.011377},{"month":2,"riseRate":0,"avgChangeRate":-0.108287},{"month":3,"riseRate":0,"avgChangeRate":-0.164923},{"month":4,"riseRate":0.333333,"avgChangeRate":0.098123},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.13008},{"month":6,"riseRate":0.666667,"avgChangeRate":0.096013},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.07008},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.11284},{"month":9,"riseRate":0,"avgChangeRate":-0.184101},{"month":10,"riseRate":0.666667,"avgChangeRate":0.017935},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.041509},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.071723}],"exchange":"SEHK","name":"心通医疗-B","nameEN":"CARDIOFLOW-B"},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"心通医疗-B(02160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供心通医疗-B(02160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"心通医疗-B,02160,心通医疗-B股票,心通医疗-B股票老虎,心通医疗-B股票老虎国际,心通医疗-B行情,心通医疗-B股票行情,心通医疗-B股价,心通医疗-B股市,心通医疗-B股票价格,心通医疗-B股票交易,心通医疗-B股票购买,心通医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"心通医疗-B(02160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供心通医疗-B(02160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}